UNOPS hosts the Stop Tuberculosis Partnership
Secretariat (STBP) as of 1 January 2015, in Geneva, Switzerland. The
vision of the Stop TB Partnership is to realize the goal of elimination of
Tuberculosis (TB) as a public health problem and, ultimately, to obtain a world
free of TB by ensuring that every TB patient has access to effective diagnosis,
treatment and cure; stopping transmission of TB; reducing the inequitable
social and economic toll of TB; and developing and implementing new preventive,
diagnostic and therapeutic tools and strategies. The Stop Partnership is
uniquely positioned to support the development and further implementation by
partners of the current and future Global Plan, acting as a coordinator and
catalyst for the range of partners engaged in the fight against TB.
Founded in 2001, the Stop TB Partnership's mission is to serve
every person who is vulnerable to TB and ensure that high-quality treatment is
available to all who need it. Stop TB partners include international and
technical organizations, government programmes, research and funding agencies,
foundations, NGOs, civil society and community groups and the private sector.
TB REACH
TB REACH is a multi-lateral funding mechanism testing and scaling
up innovative technologies and strategies aimed at increasing the number of
people detected with TB and linked to appropriate treatment. TB REACH provides
fast-track and results-based financing with rigorous,
external monitoring and evaluation (M&E) to produce strong evidence around
specific innovative technologies/approaches, so other they can be scaled up by
other donor agencies and/or national governments.
Country and Community Support for
Impact (CCS4i)
The Stop TB Partnership’s Country and Community
Support for Impact (CCS4i) supports initiatives related to the strengthening of
community systems, ensuring community leadership in the TB response, and the
implementation of Communities, Rights & Gender (CRG) tools and operational
plans that help ensure a gender transformative, human rights-based and
community-driven response in the fight against TB.
Strategic Initiatives &
Innovative Financing (SIIF)
The Stop TB Partnership’s Strategic Initiatives & Innovative
Financing (SIIF) team leads the development, roll-out, and implementation of
ground-breaking initiatives and projects to bring the “Silicon Valley” mindset
and innovations to the high burden countries and leverage multi-sectoral
collaboration to address systematic barriers in the TB and global health space.
Global Drug Facility (GDF)
As a key initiative of the Stop TB Partnership, the Global Drug Facility
(GDF) was established in 2001 to ensure access to quality-assured anti-TB
drugs, diagnostics and other supplies by employing innovative business
approaches, efficient knowledge management for evidence-driven leadership in
market management, strategic procurement, and high quality procurement and
supply services to client countries.